PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT01997112
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose supportive care
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT01997112
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01997112. Randomized; quadruple masking; primary purpose supportive care. Start 2014-01 (registry gives no type); primary completion 2019-06-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study
- Acronym
- PATH-BP
- Condition
- Blood Pressure
- Intervention (Drug)
- Paracetamol
- Intervention (Drug)
- Placebo oral capsule
- Lead sponsor
- University of Edinburgh
- Collaborator
- British Heart Foundation
- Collaborator
- National Health Service, United Kingdom
Record details
- Record id
cardio:ct-nct01997112- Content hash
84d0f67b90e3c1be1aba2d895dd33f63e9b059639c5e8d8c24d40ef827fc14f5